Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence

The limited efficacy of current immunotherapy suggests low antigen-specific T cells and immunosuppressive factors in tumor microenvironment (TME). Here, the authors develop a syringeable immunomodulatory multi-domain nanogel that can reprogram the TME and induce enhanced cancer immunotherapy.

Guardado en:
Detalles Bibliográficos
Autores principales: Chanyoung Song, Hathaichanok Phuengkham, Young Seob Kim, Van Vuong Dinh, Inho Lee, Il Woo Shin, Hong Sik Shin, Seung Mo Jin, Soong Ho Um, Hyunseung Lee, Kwan Soo Hong, Seon-Mi Jin, Eunji Lee, Tae Heung Kang, Yeong-Min Park, Yong Taik Lim
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/74f56ede70494663b8680f81b8197124
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:74f56ede70494663b8680f81b8197124
record_format dspace
spelling oai:doaj.org-article:74f56ede70494663b8680f81b81971242021-12-02T17:01:45ZSyringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence10.1038/s41467-019-11730-82041-1723https://doaj.org/article/74f56ede70494663b8680f81b81971242019-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-11730-8https://doaj.org/toc/2041-1723The limited efficacy of current immunotherapy suggests low antigen-specific T cells and immunosuppressive factors in tumor microenvironment (TME). Here, the authors develop a syringeable immunomodulatory multi-domain nanogel that can reprogram the TME and induce enhanced cancer immunotherapy.Chanyoung SongHathaichanok PhuengkhamYoung Seob KimVan Vuong DinhInho LeeIl Woo ShinHong Sik ShinSeung Mo JinSoong Ho UmHyunseung LeeKwan Soo HongSeon-Mi JinEunji LeeTae Heung KangYeong-Min ParkYong Taik LimNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-15 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Chanyoung Song
Hathaichanok Phuengkham
Young Seob Kim
Van Vuong Dinh
Inho Lee
Il Woo Shin
Hong Sik Shin
Seung Mo Jin
Soong Ho Um
Hyunseung Lee
Kwan Soo Hong
Seon-Mi Jin
Eunji Lee
Tae Heung Kang
Yeong-Min Park
Yong Taik Lim
Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
description The limited efficacy of current immunotherapy suggests low antigen-specific T cells and immunosuppressive factors in tumor microenvironment (TME). Here, the authors develop a syringeable immunomodulatory multi-domain nanogel that can reprogram the TME and induce enhanced cancer immunotherapy.
format article
author Chanyoung Song
Hathaichanok Phuengkham
Young Seob Kim
Van Vuong Dinh
Inho Lee
Il Woo Shin
Hong Sik Shin
Seung Mo Jin
Soong Ho Um
Hyunseung Lee
Kwan Soo Hong
Seon-Mi Jin
Eunji Lee
Tae Heung Kang
Yeong-Min Park
Yong Taik Lim
author_facet Chanyoung Song
Hathaichanok Phuengkham
Young Seob Kim
Van Vuong Dinh
Inho Lee
Il Woo Shin
Hong Sik Shin
Seung Mo Jin
Soong Ho Um
Hyunseung Lee
Kwan Soo Hong
Seon-Mi Jin
Eunji Lee
Tae Heung Kang
Yeong-Min Park
Yong Taik Lim
author_sort Chanyoung Song
title Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
title_short Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
title_full Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
title_fullStr Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
title_full_unstemmed Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
title_sort syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/74f56ede70494663b8680f81b8197124
work_keys_str_mv AT chanyoungsong syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT hathaichanokphuengkham syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT youngseobkim syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT vanvuongdinh syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT inholee syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT ilwooshin syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT hongsikshin syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT seungmojin syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT soonghoum syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT hyunseunglee syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT kwansoohong syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT seonmijin syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT eunjilee syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT taeheungkang syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT yeongminpark syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
AT yongtaiklim syringeableimmunotherapeuticnanogelreshapestumormicroenvironmentandpreventstumormetastasisandrecurrence
_version_ 1718382033930027008